July 15, 2016 By Tim Horn and Simon Collins INTRODUCTION The year 2016 marks 20 years since combination-based antiretroviral therapy (ART) first demonstrated durable, effective and sustained HIV control. An unprecedented period of drug discovery followed, and advances in viral…
July 15, 2016 By Polly Clayden INTRODUCTION Since the 2015 Pipeline Report global antiretroviral treatment (ART) guidelines have moved to recommending “treat all” HIV positive people. With this recommendation comes the massive task of starting and keeping everyone with HIV…
Selected updates to this chapter will be posted below prior to the 2013 edition of the Pipeline Report. Feburary 2013 Update Additional clinical trials in the Research Toward a Cure/Therapeutic Vaccines/Gene Therapies categories: Genetically Modified Peripheral Blood Stem Cell Transplant…
JULY 2012 By Polly Clayden NOTE: a postscript section at the end of this article includes periodic updates since publication in June 2012. In June 2010, the WHO and UNAIDS launched Treatment 2.0, a strategic approach to the achievement of…
By Polly Clayden NOTE: a postscript section at the end of this article includes periodic updates since publication in June 2012. In the past year—since our last Pipeline Report—there has been a flurry of activity in pediatric antiretroviral drug development…
July 2012 By Simon Collins NOTE: a postscript section at the end of this article includes periodic updates since publication in June 2012. Updates from CROI 2013. (March 2013) at the end of this article. INTRODUCTION Two aspects of antiretroviral…
July 2019 Examples of media coverage: For the First Time, Researchers Eliminated HIV From the Genomes of Living Animals – TIME, July 2, 2019 Scientists eliminate HIV in the entire genome of lab mice for the first time ever: Breakthrough paves the…
This webinar took place on June 5 and gave an overview of the recent PrEP pricing advocacy that has taken place, and provided information on how webinar attendees can get more involved in ongoing community efforts to make PrEP affordable…
TAG submitted testimony for the record for the hearing, "HIV Prevention Drug: Billions in Corporate Profits after Millions in Taxpayer Investments" at the request of members of the House Oversight and Reform Committee.
On May 14, 2019, HIV/AIDS activism lost one of its true giants. Andy Velez has been an unwavering hero to people affected by the virus around the world, and a mentor to advocates throughout his over three decades of dedicated service. No words can capture the impact of the loss of this great man.